ARCA Biopharma Inc (NASDAQ:ABIO)
| 1.80 Data as of Dec 04 |  +0.3601 / +25.01%Today’s Change | 1.13 Today|||52-Week Range 5.93 | -21.05% Year-to-Date |
Latest ABIO News | Press Releases
| Morning Market Movers Dec 04 / Benzinga |
Today’s Trading
| Previous close | 1.44 |
| Today’s open | 1.60 |
| Day’s range | -- - -- |
| Volume | 24,602,019 |
| Average volume (3 months) | 1,188,410 |
| Market cap | $22.6M |
| Dividend yield | -- |
Data as of 12/04/2013
Growth & Valuation
| Earnings growth (last year) | +38.99% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.32 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GNVCGenVec Inc | +0.04 | +2.29% |
| DMPIDelMar Pharmaceutica... | -0.09 | -9.00% |
| REPCFRepliCel Life Scienc... | +0.01 | +0.95% |
| OMBPOmni Bio Pharmaceuti... | +0.04 | +11.40% |
Data as of 3:59pm ET, 12/04/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$4.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Michael R. Bristow |
Chief Financial & Accounting Officer Patrick M. Wheeler |
Corporate headquarters Broomfield, Colorado |
Forecasts
